From what I can see, it needs to go through another 2 x trial phases before it can be sold? Who are they going to distribute it to if that is the case?
How much will this cut manufacturing capacity of their other products?
Are they being paid up front to manufacture or is that a cost MGC have the bear?
Ann: MGC Pharma Signs Agreement Targeting Anti-Viral Treatments, page-19
-
- There are more pages in this discussion • 159 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
-0.010(2.94%) |
Mkt cap ! $15.97M | |||
| Open | High | Low | Value | Volume |
| 34.5¢ | 36.5¢ | 32.5¢ | $8.486K | 24.25K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3000 | 32.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 3333 | 1 |
View Market Depth
| Last trade - 15.46pm 03/09/2024 (20 minute delay) ? |
| RGT (ASX) Chart |